Skip to main content
TTrialFinder
TrialFinder is for informational purposes only and does not provide medical advice. Always talk to your doctor.
RECRUITINGINTERVENTIONAL

Pilot-Testing Real-Time Engagement for Learning to Effectively Control Type 2 Diabetes

Real-Time Engagement for Learning to Effectively Control Type 2 Diabetes: Pilot Study

Important: This information is not medical advice. Talk to your doctor about whether a clinical trial is right for you.

About This Trial

The goal of this study is to pilot test features of a new smartphone app and to gather feedback related to wearing a continuous glucose monitor (CGM) and a Fitbit device, as well as to obtain input on health behavior-focused messages delivered through the app. The study will enroll English-speaking participants aged 16-24 years who were diagnosed with type 2 diabetes before age 18. Participants will be asked to fill out surveys about diabetes, physical activity, and diet before and after wearing a CGM for 30 days. At the end of wearing the CGM, participants will complete an interview about their experience.

Who May Be Eligible (Plain English)

Who May Qualify: - Ages 16-24 years, any sex or gender - Diagnosis of type 2 diabetes in childhood (younger than 18 years of age) - English-speaking (app in English) - Possession of personal smartphone that is compatible with FreeStyle Libre app Who Should NOT Join This Trial: • Cognitive impairment or severe psychiatric conditions that could interfere with participation in behavioral intervention for diabetes self-management Always talk to your doctor about whether this trial is right for you.

Original Eligibility Criteria

View original clinical language
Inclusion criteria: * Ages 16-24 years, any sex or gender * Diagnosis of type 2 diabetes in childhood (younger than 18 years of age) * English-speaking (app in English) * Possession of personal smartphone that is compatible with FreeStyle Libre app Exclusion Criteria: • Cognitive impairment or severe psychiatric conditions that could interfere with participation in behavioral intervention for diabetes self-management

Treatments Being Tested

OTHER

Healthmine app

Participants will wear study-provided continuous glucose monitoring device and Fitbit physical activity tracker for 30 consecutive days. During the same period, they will use an investigator-developed smartphone app (Healthmine), which is being developed to pair CGM and Fitbit data. Participants will receive up to one message about health behavior change (e.g., physical activity, nutrition) daily and will be able to use Healthmine to log exercise and dietary intake.

Locations (1)

Children's Hospital of Pittsburgh
Pittsburgh, Pennsylvania, United States